Breaking News

Sentrx CEO Resigns

To pursue efforts with his own company

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles T. Saldarini has resigned from his position at Sentrx as chief executive officer and chairman of the board to pursue efforts with his own company, The Charles T. Saldarini Group. Effective immediately, the company’s president and general manager, Michael O’Gorman, has been appointed to serve in these roles. Mr. Saldarini will remain available as a consultant and advisor.   “My experience with Sentrx has been excellent,” said Mr. Saldarini. “To be part of an organization that is helping ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters